Letter to the editor: Evidence on the use of l‐ornithine l‐aspartate in overt HE—But does it really improve prognosis? - KIVIRID

Letter to the editor: Evidence on the use of l‐ornithine l‐aspartate in overt HE—But does it really improve prognosis?

Authors: Christian Labenz, Joachim Labenz, Peter R. Galle

Published: 2021-12-27

DOI: 10.1002/hep.32309

Source: Full article

Abstract

No abstract found.